News

BENEO-Orafti S.A. has gained a positive EFSA evaluation for its prebiotic fibre inulin improving the effect on bowel function by increasing stool frequency without triggering diarrhoea. EFSA’s decision is based on six human intervention studies. The study conducted by BioTeSys – Nutritional CRO (Schulz et al., 2012, unpublished) was used to establish the conditions of use for this health claim.

BioTeSys has been testing nanoparticals with the automated genotoxicity assay FADU since 2013 for the international project. New information on nanoparticle security is available now.

BioTeSys joins in with the change from a petroleum-based economy to a sustainable, bio-based economy. BioTeSys will contribute especially its analytical skills regarding botanicals

NDA Panel member Hans Verhagen comments on actual ‘good science’ and necessary trial designs to successfully pass the EFSA evaluation process on health claims.

The test laboratory for biological and chemical analyses, cell-based test systems and study site have been proved to offer highest quality for eleven years now.

The Nutritional CRO and Test laboratory goes online with a completely restructured website. The bilingual web presentation informs companies in the food, cosmetics, and medical devices industries about the three business fields analytics, in vitro, and clinical trials.

Constipation is one of the most common health impairments in Western countries. The Nutritional CRO of BioTeSys highlights methods to analyze effects of functional food and dietary supplements on digestive health.

The new digital data analysis system A.B.O.S. offers rapid detection, classification and evaluation of biological characteristics or processes in complex data sets.

The automated assay FADU measures genotoxic effects by detecting DNA strand breaks.

BioTeSys selects Logos Technologies ALPHADAS® eSource and pro-active EDC system to give clients real time access to study data.